In this podcast, Cancer.Net Associate Editors discuss new research presented at the 2021 ASCO Annual Meeting on brain tumors, esophageal cancer, and colorectal cancer.
Read research highlights from the 2021 Quality Care Symposium, including a study on improving care for underserved people with cancer and a study investigating what causes delays in patients receiving their cancer medications.
In this webinar, experts discuss new research in gynecologic cancers, advanced melanoma, and cancer in people age 65 or older presented at the 2021 ASCO Annual Meeting.
In this podcast, Cancer.Net Associate Editors discuss new research presented at the 2021 ASCO Annual Meeting in lung cancer, breast cancer, and sarcoma and describe what this research means for people with cancer.
In this month’s “From the Editor in Chief,” Dr. Jyoti Patel reflects on the 2021 ASCO Annual Meeting theme of equity, including what it means for people with cancer and how the cancer community is working to create equity in cancer care.
In this webinar, experts discuss new research in genitourinary cancers presented at the 2021 ASCO Annual Meeting and the 2021 Genitourinary Cancers Symposium that highlighted advances in treating prostate, bladder, kidney, and testicular cancers.
La reunión anual de la American Society of Clinical Oncology (Sociedad Estadounidense de Oncología Clínica) comenzará el 4 de junio y estas son algunas de las investigaciones destacadas que se presentarán. Los temas incluyen la inmunoterapia combinada para el cáncer de esófago, radioterapia dirigida para el CPRC metastásico, el olaparib para el cáncer de mama negativo para HER2, quimioterapia adyuvante para el cáncer de cuello uterino, el pembrolizumab para el cáncer de riñón y el toripalimab para el cáncer nasofaríngeo.
The ASCO Annual Meeting begins on June 4, and here is some of the notable research that will be presented. Topics include combined immunotherapy for esophageal cancer, targeted radiation for mCRPC, olaparib for HER2-negative breast cancer, adjuvant chemotherapy for cervical cancer, pembrolizumab for kidney cancer, and toripalimab for nasopharyngeal cancer.
Colon cancer survivor Robert Greene shares how his diagnosis led him to patient advocacy and how attending the ASCO Annual Meeting has helped him feel more involved with the cancer community.
As the 2021 ASCO Annual Meeting approaches, learn why the meeting is important for people diagnosed with cancer, how research from the meeting can change cancer care, and how to register in advance.
